Vol 52, No 5 (2018)
Published online: 2018-08-17

open access

Page views 335
Article views/downloads 750
Get Citation

Connect on Social Media

Connect on Social Media

sP- and sE-selectin in stroke patients with metabolic disorders

Malgorzata Pawelczyk1, Andrzej Glabiński1, Beata Kaczorowska1, Zbigniew Baj2
DOI: 10.1016/j.pjnns.2018.08.004
Neurol Neurochir Pol 2018;52(5):599-605.

Abstract

Background

Activation of platelets and endothelial cells plays an important role in the pathogenesis of atherosclerosis and thrombotic disorders.

The aim of our study was to assess the relationship between the metabolic disorders and markers of platelet activity and vascular injury in patient with acute ischemic stroke.

Material and methods

The study group consisted of 84 patients with acute non-lacunar ischemic stroke divided into four subgroups with: (1) normolipidemia and normoglycemia, (2) normolipidemia and hyperglycemia, (3) hyperlipidemia and normoglycemia, (4) hyperlipidemia and hyperglycemia. 21 healthy subjects served as controls. We analyzed the concentration of adhesion molecules sP-selectin and sE-selectin in serum collected from all studied groups using ELISA method.

Results

We observed significantly higher sE- and sP-selectin concentration in patients with hyperglycemia and hyperlipidemia compared to both control subjects and patients with normolipidemia and normoglycemia. We did not observe additional effect of comorbid hyperlipidemia and hyperglycemia on studied markers. Soluble E- and P-selectin concentration correlated positively with LDL, TC and HbA1c level in all stroke patients.

Conclusion

Soluble E- and P-selectin, blood markers of vascular injury and platelet activation, could be useful in the assessment of atherothrombotic properties of hyperglycemia and hyperlipidemia in stroke patients.

Article available in PDF format

View PDF Download PDF file